Blockchain Registration Transaction Record

Kairos Pharma Provides Update on Clinical Trials and Strategic Developments

Kairos Pharma provides an update on its clinical trials and strategic developments, highlighting advancements in oncology therapeutics. Learn more about ENV105, KROS101, and the company's financial position.

Kairos Pharma Provides Update on Clinical Trials and Strategic Developments

This news matters as it sheds light on Kairos Pharma's advancements in oncology therapeutics, particularly its progress with ENV105 and KROS101 in combating drug resistance and immune suppression in cancer. Investors, healthcare professionals, and patients interested in innovative cancer treatments should take note of Kairos Pharma's promising developments and strong financial standing.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xadd71b5bf624d88ed7d95653a0e4ebb0fcd49673b7ec256bc6d96d7fcc71c346
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintkiwioOlU-11b56ea13aefbdbb4f9964a47b9b4772